A Study of Benralizumab in Patients With Eosinophilic Esophagitis

Clinical trial NCT04543409 · TERMINATED

Trial details

NCT number: NCT04543409
Sponsor: AstraZeneca
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Eosinophilic Esophagitis

Start date: 2020-09-22
Primary completion: 2022-09-19
Enrollment: 211

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.